ARVib Suppresses Growth of Advanced Prostate Cancer via Inhibition of Androgen Receptor Signaling

Scientists identified a novel AR/AR-V7 degrader and found that ARVib effectively degrades AR/AR-V7 protein and attenuated AR/AR-V7 downstream target gene expression in prostate cancer cells.